Back to search
FDAFDA · Food and drugs·Recall number D-0024-2023

Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India; NDC 62756-970-83

Published November 9, 2022 · Recall initiated: October 18, 2022

Summary

FDA records drug Class II recall D-0024-2023, published November 9, 2022 and initiated October 18, 2022. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: N/A; Lot: Lot #: DNC1129A, Exp 06/2023 Lot #: DNC1740A, Exp 09/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance

What to do

Voluntary: Firm initiated · Letter

Get an email if BUPRENORPHINE AND NALOXONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUPRENORPHINE AND NALOXONE
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide with the United States
UPC
0362756969834
Lot
Lot #: DNC1129A, Exp 06/2023 Lot #: DNC1740A, Exp 09/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India; NDC 62756-970-83 recalled?

Yes. FDA published recall D-0024-2023 on November 9, 2022. Reported hazard: Presence of Foreign Substance

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPRENORPHINE AND NALOXONE. UPC: 0362756969834.